Next Article in Journal
Assessment of the Tumor–Stroma Ratio and Tumor-Infiltrating Lymphocytes in Colorectal Cancer: Inter-Observer Agreement Evaluation
Previous Article in Journal
Three-Dimensional Enlow’s Counterpart Analysis: Neutral Track
 
 
Review
Peer-Review Record

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms

Diagnostics 2023, 13(14), 2338; https://doi.org/10.3390/diagnostics13142338
by Pallavi L. Nadig 1, Vibhu Joshi 1, Rakesh Kumar Pilania 1,*, Rajni Kumrah 1, Jayakanthan Kabeerdoss 2, Saniya Sharma 1, Deepti Suri 1, Amit Rawat 1 and Surjit Singh 1
Reviewer 1: Anonymous
Reviewer 2:
Diagnostics 2023, 13(14), 2338; https://doi.org/10.3390/diagnostics13142338
Submission received: 31 May 2023 / Revised: 28 June 2023 / Accepted: 6 July 2023 / Published: 11 July 2023
(This article belongs to the Section Pathology and Molecular Diagnostics)

Round 1

Reviewer 1 Report

Dear Authors,

please edit this small mistakes, than this review is suitable for publications.

The review well cover the breath of the topic and provides a clear explanation on the complexity of KD.

mistyping at pag2 lane 87 One -> one

mistyping at pag3 lane 112 Innate -> innate, Neutrophils -> neutrophils Ex -> ex

 

BW,

this reviewer

Author Response

We thank the reviewer for reviewing our manuscript. Our responses to the comments raised by reviewers are as follows:

 

Reviewer 1

Comment: Dear Authors, Please edit these small mistakes, then this review is suitable for publication. The review well cover the breath of the topic and provides a clear explanation on the complexity of KD.

mistyping at pag2 lane 87 One -> one

mistyping at pag3 lane 112 Innate -> innate, Neutrophils -> neutrophils Ex -> ex

Response: Suggestions incorporated in the revised manuscript.

Reviewer 2 Report

Line 310: Please add references for the therapeutic options listed

Line 405: Please correct 8.1. to 8. 1 gr

Line 56: the use of IVIG, to maximize

Line 78: please correct inflammations to inflammation

Figure 2: please correct inflammasom to inflammasome

Author Response

We thank the reviewer for reviewing our manuscript. Our responses to the comments raised by reviewers are as follows:

  1. General comments:

Line 310: Please add references for the therapeutic options listed

Line 405: Please correct 8.1. to 8. 1 gr

Response: Suggestions incorporated in the revised manuscript.

  1. Comments on the Quality of English Language

Line 56: the use of IVIG, to maximize

Line 78: please correct inflammations to inflammation

Figure 2: please correct inflammasom to inflammasome

Response: We thank the reviewer for the comments. We have included these suggestions in the revised manuscript.

Back to TopTop